A Genetic Screen Identifies PITX1 as a Suppressor of RAS Activity and Tumorigenicity
Open Access
- 1 June 2005
- Vol. 121 (6) , 849-858
- https://doi.org/10.1016/j.cell.2005.04.017
Abstract
No abstract availableKeywords
This publication has 29 references indexed in Scilit:
- The STAT3 Transcription Factor Is a Target for the Myc and Riboblastoma Proteins on the Cdc25A PromoterJournal of Biological Chemistry, 2005
- Recent advances in neurofibromatosis type 1Current Opinion in Neurology, 2004
- A large-scale RNAi screen in human cells identifies new components of the p53 pathwayNature, 2004
- Overexpression of Krüppel-like factor 4 in the human colon cancer cell line RKO leads to reduced tumorigenecityOncogene, 2003
- Stable suppression of tumorigenicity by virus-mediated RNA interferenceCancer Cell, 2002
- A System for Stable Expression of Short Interfering RNAs in Mammalian CellsScience, 2002
- Distinct Initiation and Maintenance Mechanisms Cooperate to Induce G1 Cell Cycle Arrest in Response to DNA DamageCell, 2000
- Dissociation among in vitro telomerase activity, telomere maintenance, and cellular immortalizationProceedings of the National Academy of Sciences, 1998
- Minimal Ras-binding domain of Raf1 can be used as an activation-specific probe for RasOncogene, 1997
- Sequence homology shared by neurofibromatosis type-1 gene and IRA-1 and IRA-2 negative regulators of the RAS cyclic AMP pathwayNature, 1990